Researchers at Columbia University Irving Medical Center are studying whether an investigational medication called larsucosterol, when added to standard medical care, may improve outcomes for people with severe alcohol-associated hepatitis. Alcohol-…
The purpose of this observational research study is to identify things that contribute to outcomes in patients with alcohol-associated liver disease who are being considered for liver transplant and who have less than 6 months of sobriety. We will look at many things including images of the liver…